Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8(+) T cells
about
T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.T-Cell Therapy Using Interleukin-21-Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor RegressionCD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patientsCombined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patientAdoptive immunotherapy against sarcomas.Exploiting cytokines in adoptive T-cell therapy of cancer.Immune responses to WT1 in patients with AML or MDS after chemotherapy and allogeneic stem cell transplantation.Tracking the Fate and Origin of Clinically Relevant Adoptively Transferred CD8+ T Cells In Vivo.Infiltration of CD8 T Cells and Expression of PD-1 and PD-L1 in Synovial Sarcoma.Considerations in T Cell Therapy Product Development for B Cell Leukemia and Lymphoma Immunotherapy.Co-delivery of human cancer-testis antigens with adjuvant in protein nanoparticles induces higher cell-mediated immune responses.The potential of the CMB305 vaccine regimen to target NY-ESO-1 and improve outcomes for synovial sarcoma and myxoid/round cell liposarcoma patients.Understanding sarcomas and other rare tumors: an interview with Robin L Jones.Characterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy Products.Dynamic changes during the treatment of pancreatic cancer.Mechanisms of Resistance to PD-1 and PD-L1 Blockade.
P2860
Q30491565-58DA9D61-B54F-422F-8A7A-E983416DEBCDQ33816848-34A8D7F5-FFD9-4828-BD58-1A004BC71606Q36951727-87EFD1AE-E85D-4096-B1B5-B6AFB209A4BDQ37047331-92046C59-CA28-4339-B517-54B1E7A63F8EQ38291193-AB2275B1-BE0E-4B86-A3D5-9CD947168614Q38525044-41A6E4F9-4148-4456-8DF0-1467E45B4EB7Q38947873-03030E2B-8E02-484D-885C-8F10C83D3566Q41975457-17EE1579-DE83-4C4B-92C1-68B6D17EACC0Q43432645-7C2180A5-81FE-4CDD-888D-A1F71EF75CB3Q45870279-E9A3A33C-443C-4B5E-A22A-CD7A8A890BFFQ46193557-BEACA185-BCA7-4AA3-815B-0C0C1141787DQ47244891-F6EAF4E9-A635-4DBC-AA93-BB28511C40ACQ47379238-267680E2-1D97-47D2-BA68-A593CAB2D80EQ50535275-96C5E6E5-DE24-4B35-833C-24E83C5B46B5Q52620434-5D222B99-4E4C-4348-BFDB-E61895C17730Q52707883-255FB341-B54D-40B9-BB67-B7DA5BD64419
P2860
Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8(+) T cells
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Tetramer guided, cell sorter a ...... -ESO-1 specific CD8(+) T cells
@ast
Tetramer guided, cell sorter a ...... -ESO-1 specific CD8(+) T cells
@en
type
label
Tetramer guided, cell sorter a ...... -ESO-1 specific CD8(+) T cells
@ast
Tetramer guided, cell sorter a ...... -ESO-1 specific CD8(+) T cells
@en
prefLabel
Tetramer guided, cell sorter a ...... -ESO-1 specific CD8(+) T cells
@ast
Tetramer guided, cell sorter a ...... -ESO-1 specific CD8(+) T cells
@en
P2093
P2860
P1476
Tetramer guided, cell sorter a ...... -ESO-1 specific CD8(+) T cells
@en
P2093
Ashley Gullett
Benjamin L Hoch
Cassian Yee
Edus H Warren
Erik A Farrar
Ernest U Conrad
Janet F Eary
Jason N Carstens
Jianhong Cao
P2860
P2888
P356
10.1186/S40425-014-0036-Y
P577
2014-10-14T00:00:00Z
P5875
P6179
1022863025